Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease

Published:2012-03-18 Issue:5 Volume:55 Page:1389-1397
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lomonaco Romina,Ortiz-Lopez Carolina,Orsak Beverly,Webb Amy,Hardies Jean,Darland Celia,Finch Joan,Gastaldelli Amalia,Harrison Stephen,Tio Fermin,Cusi Kenneth

Publisher

Wiley

Subject

Hepatology

Reference47 articles.

1. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome;Marchesini;Diabetes,2001

2. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities;Sanyal;Gastroenterology,2001

3. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms;Bugianesi;Diabetologia,2005

4. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis;Belfort;N Engl J Med,2006

5. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects;Gastaldelli;Gastroenterology,2007

Cited by 351 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipose Tissue Insulin Resistance Correlates with Disease Severity in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease: A Prospective Cohort Study;The Journal of Pediatrics;2024-11

2. Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism;Genes & Nutrition;2024-08-24

3. Mechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review;Cureus;2024-08-17

4. Therapeutic Potential of Various Intermittent Fasting Regimens in Alleviating Type 2 Diabetes Mellitus and Prediabetes: A Narrative Review;Nutrients;2024-08-14

5. Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease;Frontiers in Medicine;2024-07-31